Guy Griebel
Editor in Chief, Pharmacology Biochemistry & Behavior at Elsevier | Greater Paris Metropolitan Region
Engage
candidates 10x faster
Enjoy unlimited access and discover candidates outside of LinkedIn
Trusted by 1.4M users from 76% of Fortune 500 companies
The most accurate data ever
CCPA Compliant
GDPR Compliant
150M
Personal Emails
200M
Work Emails
100M
Direct Dials
250M
Professional Profiles
40M
Company Profiles
Find anyone, anywhere
with ContactOut today
Making remote or global hires? Connecting
with key decision-makers? We can help.
- 40 emails / month
- 3 phone numbers / month
- Works on standard LinkedIn only
-
Work emails, personal emails,
mobile numbers
No credit card required

Guy Griebel currently serves as the Editor in Chief of *Pharmacology Biochemistry & Behavior*, a prestigious journal published by Elsevier that focuses on the intersection of pharmacology and behavioral science. In this role, he leverages his extensive expertise in neuroscience and pharmacology to curate high-quality research that advances our understanding of drug effects on behavior and biochemical processes. His editorial leadership is characterized by a commitment to fostering innovative research that addresses critical challenges in the field, particularly in the context of rare and neurological disorders.
With a robust background as the Head of External Innovation for Rare and Neurological Disorders at Sanofi, Guy has honed his ability to lead cross-functional teams in the discovery and clinical testing of novel therapeutics. His previous experience as Global Head of the Department of Neuroscience Pharmacology allowed him to spearhead initiatives that integrated scientific evaluation with practical applications in drug development. This unique blend of skills enables him to critically assess submissions to the journal, ensuring that published studies not only contribute to academic discourse but also have real-world implications for drug research and development.
Guy's proficiency in animal models and psychopharmacology, combined with his deep understanding of molecular biology and clinical development, positions him as a thought leader in the pharmaceutical sector. His editorial insights are invaluable in guiding researchers to explore innovative methodologies and therapeutic strategies, ultimately driving forward the field of pharmacology and its impact on behavioral health. Through his work, Guy Griebel continues to shape the future of pharmacological research, fostering a collaborative environment that encourages the exploration of groundbreaking ideas and solutions.
Editor in Chief, Pharmacology Biochemistry & Behavior at Elsevier in January 2015 to Present
Head of Search and Evaluation, Rare and Neurological Disorders at Sanofi in January 2021 to Present
Head of External Innovation, Multiple Sclerosis & Neuroscience at Sanofi in June 2019 to January 2021
Senior Director Sanofi Genzyme Neuroscience at Sanofi in November 2016 to May 2019
Director Evaluation & Valorization Neuroscience at Sanofi in April 2015 to October 2016
Head, Assets Valorization and Opportunities Evaluation, Neuroscience at Sanofi in June 2012 to March 2015
Scientific Advisor and Expert, Neuroscience Drug Discovery Research at Sanofi in February 2010 to May 2012
Global Head, Psychopharmacology Department at Sanofi in November 2002 to January 2010
Group Leader, Psychopharmacology Department at Sanofi in January 2000 to October 2002
Team Leader, Psychopharmacology Department at Sanofi in February 1996 to December 1999
Principal Scientist, Psychopharmacology Department at Synthélabo, CNS Research Department in February 1995 to December 1995
Post-doctoral fellow at University of Canterbury in January 1995 to February 1995
Post-doctoral fellow at University of Hawaii at Manoa in October 1993 to December 1994
See more
See less
Université de Strasbourg, Ph.D. thesis, Psychopharmacology
Université de Strasbourg, DEA (Diplôme d'Etudes Approfondies), Neurosciences
Université de Strasbourg, 1. Maîtrise (M.Sc.), Psychology
See more
See less
Neuroscience
Animal Models
Pharmacology
Cognition
Psychopharmacology
Drug Discovery
Scientific Editing
Scientific Communication
New Business Development
Psychiatry Research
Scientific Evaluation
Psychopharmacologie
R&D
Pharmaceutical Industry
Biotechnologie
Pharmacologie
Biologie moléculaire
Recherche médicamenteuse
Neurosciences
In vivo
Modèle animal
Sciences de la vie
Biochimie
Recherche
Life Sciences
Secteur pharmaceutique
Essais cliniques
Développement clinique
Développement de médicament
See more
See less
What is Guy Griebel email address?
Email Guy Griebel at [email protected] and [email protected]. This email is the most updated Guy Griebel's email found in 2025.
What is Guy Griebel phone number?
Guy Griebel phone number is +33673689796.
How to contact Guy Griebel?
To contact Guy Griebel send an email to [email protected] or [email protected]. If you want to call Guy Griebel try calling on +33673689796.
What company does Guy Griebel work for?
Guy Griebel works for Elsevier
What is Guy Griebel's role at Elsevier?
Guy Griebel is Editor in Chief, Pharmacology Biochemistry & Behavior
What industry does Guy Griebel work in?
Guy Griebel works in the Think Tanks industry.
Guy Griebel Email Addresses
Guy Griebel Phone Numbers
looking for?
Find personal and work emails for over 250M professionals.
Top Searched People
Actor and singer
TV personality ‧ Kim Richards' daughter
People like Guy Griebel
Director at The Drunken Cookie
Vice President, Regional Quality Head, North America at Sanofi Genzyme
Associate Vice President - US Marketing Head Immunology - Respiratory at Sanofi Genzyme
Director, Global Scientific Communications - Immunology at Sanofi Genzyme
Senior Director, Scientific & Medical Affairs at Sanofi Pasteur
Vice President Strategic Partnerships & Channel Sales at FenixCommerce Inc.
VP, Marketing & Buying Enablement at SmarTECHS
CEO, Welcome.US at Welcome.US
Owner at Joanne McCormick - Sincerely Jo
Co-Founder at Ismailis Rise Up
Author, The Wake Up at Hachette Book Group
Interventional Cardiologist at Erlanger Medical Center, Parkridge Medical Center and Memorial Hospital
President at AmalgamRx
Technical Advisor at HyperTattoo
Partner at NAYAH
Principal, Advisory Services at EY
President and CEO at Neurogastrx, Inc.
Policy Manager at Twitter
Communications Consultant at Be An Arts Hero
SVP, Network Strategy & Development; Executive Director, Center for Regional Healthcare Innovation at Westchester Medical Center, a member of WMCHealth
Software Engineer - Project Lead at SimpleNexus
Senior Production Manager / Lead Producer at JCPenney Photo Studio
Managing Partner at The Cohen Group, LLC
Director of International Operations at Operation Underground Railroad
Global Tax Policy Network Leader at EY
VP & General Counsel, Corporate Secretary at IP Corporation
President MRO Group at GA Telesis
Head of Financial Audits at Palantir Technologies
Show more
Show less